Ullrich K, Möller H, Weglage J, Schuierer G, Bick U, Ludolph A, Hahn-Ullrich H, Fünders B, Koch H G
Department of Paediatrics, University of Münster, Germany.
Acta Paediatr Suppl. 1994 Dec;407:78-82. doi: 10.1111/j.1651-2227.1994.tb13459.x.
In adolescents and adults with PKU, blood phenylalanine levels above 10 mg/dl are generally associated with white matter changes in MRI. The grade of these changes is correlated to most recent blood phenylalanine levels. Based on studies using T2 relaxometry the MRI changes seem to be the consequence of a reversible dysmyelination. The clinical relevance of these white matter changes remains unclear as the extent of MRI alterations did not correlate with IQ, neurological and electrophysiological deficits of the patients. The intracerebral phenylalanine concentration as measured by protonspectroscopy amounts to about 50% of blood phenylalanine concentrations. Preliminary data indicate that brain phenylalanine levels remain constant if blood concentrations exceed 20 mg/dl. This might be of clinical relevance for the treatment of adolescent and adult PKU patients.
在青少年和成人苯丙酮尿症患者中,血液苯丙氨酸水平高于10mg/dl通常与MRI上的白质改变有关。这些改变的程度与最近的血液苯丙氨酸水平相关。基于使用T2弛豫测量法的研究,MRI改变似乎是可逆性脱髓鞘的结果。这些白质改变的临床相关性仍不清楚,因为MRI改变的程度与患者的智商、神经和电生理缺陷无关。通过质子光谱法测量的脑内苯丙氨酸浓度约为血液苯丙氨酸浓度的50%。初步数据表明,如果血液浓度超过20mg/dl,脑苯丙氨酸水平保持恒定。这可能对青少年和成人苯丙酮尿症患者的治疗具有临床意义。